You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Erythromycin - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for erythromycin and what is the scope of freedom to operate?

Erythromycin is the generic ingredient in fifty-two branded drugs marketed by Dr Reddys Labs Sa, Parke Davis, Warner Chilcott Llc, Hospira, Arbor Pharms Llc, Barr, Mylan, Altana, Encube, Fougera Pharms, Padagis Us, Syosset, Bausch And Lomb, Pharmaderm, Pharmafair, Sentiss, Dista, Bausch, Paddock Llc, Taro, Arbor Pharms Inc, Merz Pharms, Micro Labs, Epic Pharma Llc, Alpharma Us Pharms, Lilly, Pai Holdings Pharm, Pharmobedient Cnsltg, Renaissance Pharma, Dow Pharm, Westwood Squibb, Ivax Sub Teva Pharms, Johnson And Johnson, Azurity, Amneal Pharms Co, Torrent, Solvay, Robins Ah, Alembic, Alkem Labs Ltd, Cadila Pharms Ltd, Teva Pharms Usa Inc, Zydus, Zydus Pharms, Watson Labs, Cosette, Life Labs, Amneal Pharms, Ani Pharms, Par Pharm Inc, Ross Labs, Pharmacia And Upjohn, Naska, Wyeth Ayerst, Aurobindo Pharma Usa, Alra, Abbott, Elkins Sinn, Abraxis Pharm, Baxter Hlthcare, Exela Pharma, Nexus, Teva Parenteral, Bristol, Warner Chilcott, Lederle, Purepac Pharm, Bristol Myers Squibb, and Pfizer, and is included in one hundred and thirty-eight NDAs. Additional information is available in the individual branded drug profile pages.

There are one hundred and three drug master file entries for erythromycin. Thirty-three suppliers are listed for this compound.

Drug Prices for erythromycin

See drug prices for erythromycin

Drug Sales Revenue Trends for erythromycin

See drug sales revenues for erythromycin

Recent Clinical Trials for erythromycin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityN/A
Sohag UniversityPhase 2/Phase 3
Eastern Virginia Medical SchoolN/A

See all erythromycin clinical trials

Pharmacology for erythromycin
Medical Subject Heading (MeSH) Categories for erythromycin

US Patents and Regulatory Information for erythromycin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms ERYTHROMYCIN ETHYLSUCCINATE erythromycin ethylsuccinate GRANULE;ORAL 062055-003 Nov 2, 2018 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Bristol BRISTAMYCIN erythromycin stearate TABLET;ORAL 061304-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Mylan ERYGEL erythromycin GEL;TOPICAL 050617-001 Oct 21, 1987 AT RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Naska ERYTHROMYCIN ETHYLSUCCINATE erythromycin ethylsuccinate SUSPENSION;ORAL 062674-001 Mar 10, 1987 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Barr E-BASE erythromycin TABLET, DELAYED RELEASE;ORAL 062999-001 Nov 25, 1988 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Dista ILOSONE erythromycin estolate TABLET, CHEWABLE;ORAL 061895-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Watson Labs ERYTHROMYCIN STEARATE erythromycin stearate TABLET;ORAL 062121-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.